BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8394035)

  • 1. Phosphotriesterase decreases paraoxon toxicity in mice.
    Kaliste-Korhonen E; Ylitalo P; Hänninen O; Raushel FM
    Toxicol Appl Pharmacol; 1993 Aug; 121(2):275-8. PubMed ID: 8394035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphotriesterase--a promising candidate for use in detoxification of organophosphates.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Fundam Appl Toxicol; 1994 Nov; 23(4):578-84. PubMed ID: 7867909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of organophosphate-inactivated esterases with phosphotriesterase.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Fundam Appl Toxicol; 1996 Jun; 31(2):210-7. PubMed ID: 8789787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats.
    Costa LG; McDonald BE; Murphy SD; Omenn GS; Richter RJ; Motulsky AG; Furlong CE
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):66-76. PubMed ID: 1690462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.
    Petrikovics I; Hong K; Omburo G; Hu QZ; Pei L; McGuinn WD; Sylvester D; Tamulinas C; Papahadjopoulos D; Jaszberenyi JC; Way JL
    Toxicol Appl Pharmacol; 1999 Apr; 156(1):56-63. PubMed ID: 10101099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of phosphotriesterase within murine erythrocytes.
    Pei L; Omburo G; McGuinn WD; Petrikovics I; Dave K; Raushel FM; Wild JR; DeLoach JR; Way JL
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):296-301. PubMed ID: 8122276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselectivity of phosphotriesterase with paraoxon derivatives: a computational study.
    Zhan D; Guan S; Jin H; Han W; Wang S
    J Biomol Struct Dyn; 2016; 34(3):600-11. PubMed ID: 25929154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase.
    Pei L; Petrikovics I; Way JL
    Fundam Appl Toxicol; 1995 Dec; 28(2):209-14. PubMed ID: 8835230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrogation of the Substrate Profile and Catalytic Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of Hydrolyzing Organophosphate Flame Retardants and Plasticizers.
    Xiang DF; Bigley AN; Ren Z; Xue H; Hull KG; Romo D; Raushel FM
    Biochemistry; 2015 Dec; 54(51):7539-49. PubMed ID: 26629649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibition and acetylcholine accumulation following intracerebral administration of paraoxon in rats.
    Ray A; Liu J; Karanth S; Gao Y; Brimijoin S; Pope C
    Toxicol Appl Pharmacol; 2009 May; 236(3):341-7. PubMed ID: 19272400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eptastigmine-phosphotriesterase combination in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detoxification of organophosphate pesticides using a nylon based immobilized phosphotriesterase from Pseudomonas diminuta.
    Caldwell SR; Raushel FM
    Appl Biochem Biotechnol; 1991 Oct; 31(1):59-73. PubMed ID: 1665681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Pseudomonas phosphotriesterase activity in the fall armyworm confers resistance to insecticides.
    Dumas DP; Wild JR; Raushel FM
    Experientia; 1990 Jul; 46(7):729-31. PubMed ID: 2164956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in the hydrolysis of substrates by the phosphotriesterase from Pseudomonas diminuta.
    Donarski WJ; Dumas DP; Heitmeyer DP; Lewis VE; Raushel FM
    Biochemistry; 1989 May; 28(11):4650-5. PubMed ID: 2548585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
    Butler EG; Eckerson HW; La Du BN
    Drug Metab Dispos; 1985; 13(6):640-5. PubMed ID: 2867864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro.
    Kaliste-Korhonen E; Tuovinen K; Hänninen O
    Hum Exp Toxicol; 1996 Dec; 15(12):972-8. PubMed ID: 8981101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDTA-resistant and sensitive phosphotriesterase activities associated with albumin and lipoproteins in rabbit serum.
    Sogorb MA; Sánchez I; López-Rivadulla M; Céspedes V; Vilanova E
    Drug Metab Dispos; 1999 Jan; 27(1):53-9. PubMed ID: 9884309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antagonism of phosphorus-containing heterocyclics with the anticholinesterase agent Phosphacol (paraoxon)].
    Garaev RS
    Eksp Klin Farmakol; 1996; 59(1):68-70. PubMed ID: 8704640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.